In clinical research, the focus on efficiency and patient-centered solutions is transforming trial execution. The industry is increasingly prioritizing the removal of barriers to patient participation, addressing logistical challenges, ensuring safety, and enhancing overall participant experience. Innovative strategies are streamlining processes, reducing patient burden, and improving research outcomes. Leading this transformation is mdgroup, providing comprehensive support to pharmaceutical and biotech companies. Its services, including patient reimbursements, safe transport, remote visits, personalized support, healthcare staffing, and clinical equipment logistics, drive improvements in both site-based and decentralized trials. By utilizing cutting-edge technology and a global network, mdgroup sets new standards in patient-centric clinical trial management.
mdgroup is a leader in supporting pharmaceutical and biotech companies in patient recruitment, engagement, and retention for clinical trials. Its global ecosystem of clinical trial solutions includes services such as patient reimbursements, safe transport, in-home health visits, clinical equipment logistics, and healthcare professional staffing. The company’s mission is to enhance patient experiences in both site-based and decentralized clinical trials. Key services include the “on-demand” service, which offers personalized concierge support, compliant travel, accommodation, logistics, and reimbursements, ensuring smoother trial participation. The “mobile health” service advances decentralized trials by facilitating visits directly at patients’ locations, improving recruitment, retention, and outcomes. Additionally, the “navigator” service provides tailored patient support, reducing drop-out rates through personalized care.
With extensive experience across various therapeutic areas, including rare diseases, oncology, cardiology, and immunology, mdgroup plays a critical role in advancing medical research. Its cutting-edge technology platform, Primarius, integrates services across the clinical trial journey, ensuring seamless experiences for patients, sponsors, and sites. The company continues to expand its global reach, focusing on accessibility, patient-centricity, and advancing clinical trial technology, all while maintaining its commitment to supporting patient health and wellness.
Recognized by Insights Care as one of the 10 Leading Pharmaceutical Companies to Watch in 2024, mdgroup is at the forefront of reshaping the landscape of clinical trials by addressing traditional barriers to patient participation and enhancing the overall experience.
Read Also: Prashant Mehta | Most Influential Chief Investment Officers of the Year
